Lactobacillus Paracasei CNCM I 1572 is Better than Placebo in Preventing Acute Diverticulitis Occurrence (Revised Manuscript 661a120f-b910-4133-ab7e-4bd3e1713c96)
Abstract
Data analysing the impact of probiotics in preventing the occurrence of acute diverticulitis (AD) in patients having symptomatic uncomplicated diverticular disease (SUDD) of the colon are still scarce. We assessed the effectiveness of Lactobacillus paracasei CNCM I 1572 in preventing the first episode of AD in patients with SUDD. A post-hoc analysis of a 12-month, multicentre, double-blind, placebo-controlled study was conducted. One hundred and five patients were randomly enrolled in a double-blind fashion into Group L (Lactobacillus paracasei CNCM I 1572, 24 billion CFU/day) and Group P (placebo). Patients received treatment for 10 days per month for 12 months. The occurrence of AD was defined according to radiological criteria from abdominal computerised tomography. AD occurred in 7 of the analysed patients during follow-up: 6 patients were in group P and one patient in group L (p = 0.036). AD was uncomplicated in 6 out of 7 patients, while one patient receiving placebo underwent surgery due to free perforation. During the follow-up, mild adverse events (7.27% in group L and 9.0% in group P, p = 0.90) were recorded and did not necessitate treatment discontinuation. Lactobacillus paracasei CNCM I 1572 appears to be more effective than placebo in preventing the first episode of AD in SUDD patients. It could therefore be a real chance for the prevention of this diverticular disease complication. We need more data from prospective placebo-controlled trials enrolling a large…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 7 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.